Regiocit 5.29 g

Regiocit 5.29 G is a sodium citrate solution used for anticoagulation during extracorporeal procedures. This pharmaceutical is manufactured by Vantive ULC in Canada.

Regiocit 5.29 G is primarily used for anticoagulation in extracorporeal procedures. Sodium citrate, the active ingredient, helps prevent blood clotting during processes like dialysis or blood transfusion. This solution is designed to maintain blood flow and ensure the safety of these medical procedures.

When used as directed, Regiocit 5.29 G helps to inhibit blood clotting, allowing for smooth extracorporeal procedures. The solution works by binding calcium ions, which are essential for the clotting process. This can help maintain the integrity of blood components during procedures.

Regiocit 5.29 G should be handled with care and stored according to manufacturer guidelines. It is important to follow proper administration protocols to avoid complications. Always consult healthcare professionals for specific handling and safety instructions.

Regiocit 5.29 G may interact with other medications or substances that affect blood clotting. It is important to inform healthcare providers about all medications being taken to avoid potential interactions. Always follow medical advice regarding the use of this solution.